<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6222776</article-id><article-id pub-id-type="doi">10.3390/molecules23081857</article-id><article-id pub-id-type="publisher-id">molecules-23-01857</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Oregano Essential Oil Attenuates RAW264.7 Cells from Lipopolysaccharide-Induced Inflammatory Response through Regulating NADPH Oxidase Activation-Driven Oxidative Stress</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-8651-0738</contrib-id><name><surname>Cheng</surname><given-names>Chuanshang</given-names></name><xref ref-type="aff" rid="af1-molecules-23-01857">1</xref><xref ref-type="author-notes" rid="fn1-molecules-23-01857">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Zou</surname><given-names>Yi</given-names></name><xref ref-type="aff" rid="af1-molecules-23-01857">1</xref><xref ref-type="author-notes" rid="fn1-molecules-23-01857">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Peng</surname><given-names>Jian</given-names></name><xref ref-type="aff" rid="af1-molecules-23-01857">1</xref><xref ref-type="aff" rid="af2-molecules-23-01857">2</xref><xref rid="c1-molecules-23-01857" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Miguel</surname><given-names>Maria G.</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-molecules-23-01857"><label>1</label>Department of Animal Nutrition and Feed Science, College of Animal Science and Technology, Huazhong Agricultural University, Wuhan 430070, China; <email>chengcs1989@gmail.com</email> (C.C.); <email>juicewaterzouyi@gmail.com</email> (Y.Z.)</aff><aff id="af2-molecules-23-01857"><label>2</label>The Cooperative Innovation Center for Sustainable Pig Production, Wuhan 430070, China</aff><author-notes><corresp id="c1-molecules-23-01857"><label>*</label>Correspondence: <email>pengjian@mail.hzau.edu.cn</email>; Tel.: +86-27-8728-6912</corresp><fn id="fn1-molecules-23-01857"><label>&#x02020;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>26</day><month>7</month><year>2018</year></pub-date><pub-date pub-type="collection"><month>8</month><year>2018</year></pub-date><volume>23</volume><issue>8</issue><elocation-id>1857</elocation-id><history><date date-type="received"><day>08</day><month>6</month><year>2018</year></date><date date-type="accepted"><day>20</day><month>7</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; 2018 by the authors.</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Oregano is an aromatic plant widely distributed throughout the Mediterranean area and in Asia. Recent studies have revealed that the anti-inflammatory effect of essential oil in this plant. However, the mechanisms underlying the therapeutic potential have not been well elucidated. This study determined whether oregano essential oil (OEO) exerts an anti-inflammatory effect on lipopolysaccharide (LPS)-treated murine macrophage cells (RAW264.7 cells) in vitro and elucidated the possible underlying molecular mechanisms. The results showed that OEO (2.5&#x02013;10 &#x003bc;g/mL) inhibited the expression and secretion of interleukin-1 beta (IL-1&#x003b2;), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-&#x003b1;) in RAW264.7 cells treated with LPS (1 &#x003bc;g/mL). Consistent with the pro-inflammatory gene expression, the OEO treatment efficiently reduced the LPS-induced activation of mitogen-activated protein kinase, protein kinase B, and nuclear factor &#x003ba;B in RAW264.7 cells. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase inhibition in Nox2 protein-silenced cells attenuated the mRNA expression of IL-1&#x003b2;, IL-6, and TNF-&#x003b1; in the LPS-induced RAW264.7 cells. The OEO inhibited the LPS-induced elevation of NADPH oxidase and oxidative stress. This result suggests that LPS induces RAW264.7 cell inflammation through the NADPH oxidase-mediated production of reactive oxygen species (ROS). In conclusion, OEO protects against the LPS-induced RAW264.7 cell inflammatory response through the NADPH oxidase/ROS pathway.</p></abstract><kwd-group><kwd>oregano essential oil</kwd><kwd>inflammation</kwd><kwd>oxidative stress</kwd><kwd>NADPH oxidase</kwd></kwd-group></article-meta></front><body><sec id="sec1-molecules-23-01857"><title>1. Introduction</title><p>Macrophages, which are ubiquitously distributed in tissues via the mononuclear phagocyte system, support homeostasis and host defense against intracellular parasitic bacteria and pathogenic protozoa [<xref rid="B1-molecules-23-01857" ref-type="bibr">1</xref>]. Lipopolysaccharide (LPS), a component of the outer membrane of Gram-negative bacteria, stimulates macrophage activation [<xref rid="B2-molecules-23-01857" ref-type="bibr">2</xref>]. Activated macrophages play an important role in inflammatory response by producing cytokines, including interleukin-1 beta (IL-1&#x003b2;), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-&#x003b1;) [<xref rid="B1-molecules-23-01857" ref-type="bibr">1</xref>]. An inflammatory response is a crucial protective attempt of the host&#x02019;s defense to remove injurious stimuli and initiate healing, but the overproduction of inflammatory mediators is a major cause of tissue damage, sepsis, and cancer [<xref rid="B3-molecules-23-01857" ref-type="bibr">3</xref>].</p><p>Reactive oxygen species (ROS) overproduction and cell redox imbalance play a central role in the pathophysiology of the inflammatory response [<xref rid="B4-molecules-23-01857" ref-type="bibr">4</xref>]. Substantial evidence implicates oxidative stress as an important pathogenic factor in inflammatory response [<xref rid="B5-molecules-23-01857" ref-type="bibr">5</xref>]. ROS are intracellularly generated from several sources, including mitochondrial respiration, cytochrome P450, and the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase system [<xref rid="B6-molecules-23-01857" ref-type="bibr">6</xref>]. Phagocyte NADPH oxidase 2 (NOX2) is the major source of ROS generation in the macrophage response to LPS [<xref rid="B7-molecules-23-01857" ref-type="bibr">7</xref>]. Therefore, LPS may induce an inflammatory response through NADPH oxidase activation-driven oxidative stress. Likewise, the inhibition of the ROS production using inhibitors against NADPH oxidase is proposed as an alternative approach to conventional antioxidant therapies against LPS-induced inflammation.</p><p>Oregano (<italic>Origanum vulgare</italic> L.) is an aromatic plant widely distributed throughout the Mediterranean area and Asia [<xref rid="B8-molecules-23-01857" ref-type="bibr">8</xref>]. Oregano essential oil (OEO) is a concentrate of natural plant products that contain volatile aromatic compounds, and the major constituents of OEO have been characterized. This volatile aromatic compound exhibits several biological actions, including anti-bacterial and anti-oxidative activities [<xref rid="B9-molecules-23-01857" ref-type="bibr">9</xref>]. Carvacrol and thymol, the two main phenolic derivatives that constitute about 81.9 and 3.5% of OEO, are principally responsible for the activities [<xref rid="B9-molecules-23-01857" ref-type="bibr">9</xref>]. In addition, other minor constituents such as &#x003b3;-terpinene and &#x003c1;-cymene, two monoterpene hydrocarbons that constitute about 4.49 and 3.07% of OEO, respectively, also contribute to the activities [<xref rid="B10-molecules-23-01857" ref-type="bibr">10</xref>]. Recent studies have shown that OEO prevents inflammation in vitro and in vivo [<xref rid="B11-molecules-23-01857" ref-type="bibr">11</xref>,<xref rid="B12-molecules-23-01857" ref-type="bibr">12</xref>]. However, the regulatory mechanisms of OEO that reduce the inflammatory responses have not been reported. In the present study, we investigated the effect of OEO on the NADPH oxidase-mediated oxidative stress and the inflammation of murine macrophage cells (RAW264.7 cells) in response to LPS. We also determined whether the anti-inflammatory effect of OEO is associated with the inhibition of NADPH oxidase-derived ROS generation.</p></sec><sec id="sec2-molecules-23-01857"><title>2. Materials and Methods</title><sec id="sec2dot1-molecules-23-01857"><title>2.1. Chemicals and Reagents</title><p>Roswell Park Memorial Institute (RPMI) 1640 medium and fetal bovine serum (FBS) were purchased from GIBCO BRL (Grand Island, NY, USA). The oregano essential oil (OEO) was obtained from Meritech Bioengineering Co. Ltd. (Guangzhou, China), and its composition is shown in <xref ref-type="app" rid="app1-molecules-23-01857">Supplementary Table S1 and Figure S1</xref>. The processing method of the OEO included mixing seeds, seedling cultivation, planting, harvesting, distillation and refining, quality inspection, qualified essential oil screening, and storage. The OEO was completely soluble in dimethyl sulphoxide (DMSO). The LPSs (<italic>Escherichia coli</italic> O127: B8) were from Sigma (St. Louis, MO, USA). The 2&#x02032;,7&#x02032;-dichlorofluorescein-diacetate (DCFH2-DA), diphenyleneiodonium chloride (DPI), and 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2<italic>H</italic>-tetrazolium bromide (MTT) were from Sigma-Aldrich (St. Louis, MO, USA). The anti-phospho p38 MAPK, anti-phospho anti-c-Jun N-terminal protein kinase (JNK), and anti-&#x003b2;-actin were from Cell Signaling Technology (Beverly, MA, USA). The anti-p38 MAPK, JNK, and anti-extracellular signal-regulated kinases 1/2 (ERK1/2) were from Affinity Biosciences (Columbus, OH, USA). The anti-proliferating cell nuclear antigen (PCNA) was from BD Transduction Laboratories (San Diego, CA, USA). The RAW264.7 cells were obtained from the Chinese Academy of Sciences Institution (Chinese Academy of Sciences, Guangzhou, China). The OEO was dissolved in the serum-containing medium to achieve the final desired concentration.</p></sec><sec id="sec2dot2-molecules-23-01857"><title>2.2. MTT Assay</title><p>The RAW264.7 cells (2 &#x000d7; 10<sup>4</sup> per well in a 96-well plate) were washed with phosphate-buffered saline (PBS) and then added to 10 &#x003bc;L of 5 mg/mL MTT (dissolved in PBS). After being incubated at 37 &#x000b0;C for 4 h, the MTT solution was carefully removed and the resulting formazan crystals were dissolved in 150 &#x003bc;L of DMSO. Th absorbance was measured using a spectrophotometer (Biomate 5, Thermo Electron Corporation, Waltham, MA, USA) at the wavelength of 490 nm. The effect of OEO and LPS on the cell viability was assessed as the percentage of viable cells compared with the vehicle-treated control cells (received cell-grade DMSO at a safe concentration), which were arbitrarily assigned a viability of 100%.</p></sec><sec id="sec2dot3-molecules-23-01857"><title>2.3. Lactate Dehydrogenase (LDH) Release Assay</title><p>After the treatment period, the RAW264.7 cells culture medium was collected and assayed for LDH activity. The LDH release assay was detected using an LDH cytotoxicity assay kit (Nanjing Jiancheng Institute of Bioengineering, Nanjing, China), according to the manufacturer&#x02019;s protocol.</p></sec><sec id="sec2dot4-molecules-23-01857"><title>2.4. Enzyme-Linked Immune Sorbent Assay for Quantification of Cytokines</title><p>The RAW264.7 cells (2 &#x000d7; 10<sup>5</sup> cells per well in a 24-well plate) supernatants were centrifuged at 10,000&#x000d7; <italic>g</italic> at 4 &#x000b0;C for 10 min to remove debris, and stored at 80 &#x000b0;C until analysis. IL-1&#x003b2;, IL-6, and TNF-&#x003b1; were quantified using ELISA kits (R&#x00026;D, Minneapolis, MN, USA), according to the manufacturer&#x02019;s instructions.</p></sec><sec id="sec2dot5-molecules-23-01857"><title>2.5. Quantitative PCR</title><p>The total RNA from the RAW264.7 cells (2 &#x000d7; 10<sup>5</sup> cells per well in a 24-well plate) was isolated using a Trizol reagent (Invitrogen, Carlsbad, CA, USA), according to the manufacturer&#x02019;s instructions. The concentration and integrity of the RNA were measured at a 260/280 nm ratio. For the cDNA synthesis, 2.5 &#x003bc;g of RNA was reverse-transcribed using the Prime Script RT reagent kit (Takara, Tokyo, Japan), according to the manufacturer&#x02019;s protocol. The PCR primers were designed using Primer 5.0 software, and the primer sequences have been shown in <xref rid="molecules-23-01857-t001" ref-type="table">Table 1</xref>. The &#x003b2;-actin gene was used as invariant housekeeping gene internal control. Real-time PCR was performed, as described in our previous study [<xref rid="B13-molecules-23-01857" ref-type="bibr">13</xref>]. Briefly, the reactions were as follows: 50 &#x000b0;C for 2 min, 95 &#x000b0;C for 30 s for one cycle; then 95 &#x000b0;C for 5 s, 59 &#x000b0;C for 15 s, and 72 &#x000b0;C for 45 s for 40 cycles. The relative gene expression was quantified by the comparative 2<sup>&#x02212;&#x02206;&#x02206;CT</sup> method [<xref rid="B14-molecules-23-01857" ref-type="bibr">14</xref>]. All of the reactions were conducted in triplicate.</p></sec><sec id="sec2dot6-molecules-23-01857"><title>2.6. Western Blotting Analysis</title><p>The RAW264.7 cells (1 &#x000d7; 10<sup>6</sup> cells per well in a 6-well plate) were collected and the total protein was extracted using a RIPA buffer containing protease inhibitors or phosphatase inhibitors (Thermo Scientific, Waltham, MA, USA). To determine the subcellular localization of nuclear factor kappa B (NF-&#x003ba;B) p65, nuclear extracts were prepared using a nuclear/cytosol fractionation kit (BestBio, Shanghai, China). A bicinchoninic acid (BCA) protein assay was used to determine the protein concentrations, and 30 &#x003bc;g of protein was loaded per sample. Western blotting was performed, as described in our previous study [<xref rid="B13-molecules-23-01857" ref-type="bibr">13</xref>]. The chemiluminescence detection was performed using an ECL reagent (Thermo Scientific). Specific bands were detected, analyzed, and quantified by Image J Software (v 1.44, Bethesda, Rockville, MD, USA).</p></sec><sec id="sec2dot7-molecules-23-01857"><title>2.7. Measurement of ROS Generation</title><p>After the treatment period, the RAW264.7 cells (2 &#x000d7; 10<sup>4</sup> per well in a 96-well plate) were washed with PBS and then incubated with 10 &#x003bc;M DCFH<sub>2</sub>-DA (dissolved in PBS). After incubated at 37 &#x000b0;C for 30 min, DCFH<sub>2</sub>-DA was removed and RAW264.7 cells were washed in PBS. Intracellular ROS, as indicated by DCF fluorescence, was observed with a fluorescence microscope (Nikon, Minato ku, Japan). The fluorescence intensity was quantified using a multidetection reader (Biotek, Winooski, VT, USA) at the excitation 480 nm and emission 520 nm. The RAW264.7 cells supernatant of the ROS level was measured by chemiluminescence assay using luminol, as described in our previous study [<xref rid="B13-molecules-23-01857" ref-type="bibr">13</xref>]. The results were expressed as relative light units (RLU).</p></sec><sec id="sec2dot8-molecules-23-01857"><title>2.8. Assessment of Lipid Peroxidation, Intracellular GSH and GSH: GSSG Ration, and NADPH Oxidase Activity</title><p>IPEC-J2 cells (1 &#x000d7; 10<sup>5</sup> per well in a 6-well plate) were washed twice with cold PBS and harvested by a cell scraper. The harvested cells were lysed by sonication on ice, and the supernatant of the centrifugate (1300&#x000d7; <italic>g</italic> at 4 &#x000b0;C for 15 min) was collected. Lipid peroxidation was assayed by the measurement of the malondialdehyde (MDA) level, as described previously [<xref rid="B13-molecules-23-01857" ref-type="bibr">13</xref>]. The glutathione (GSH) levels and GSH: oxidized glutathione (GSSG) ration were determined using a commercial kit (Nanjing Jiancheng Institute of Bioengineering, Nanjing, China). The NADPH oxidase activity was quantified using ELISA kits (R&#x00026;D), according to the manufacturer&#x02019;s instructions.</p></sec><sec id="sec2dot9-molecules-23-01857"><title>2.9. SiRNA Transfection in RAW264.7 Cells</title><p>The NOX2-siRNA primer was as follows: 5&#x02032;-GAGUUUGGAAGAGCAUAAUTT-3&#x02032; (sense) and 5&#x02032;-AUUAUGCUCUUCCAAACUCTT-3&#x02032; (anti-sense). The siRNA targeting the mouse NOX mRNA was obtained from Genepharma (Shanghai, China). The RAW264.7 cells were grown in 6-well plates (2 &#x000d7; 10<sup>4</sup> cells/well). After beng cultured for 24 h, the cells were then subjected to transient transfection with either a 100 nM NOX2-siRNA or a scrambled duplex, using the siRNA transfection reagent Lipofectamine 2000, according to the manufacturer&#x02019;s instructions. After a 6 h incubation, the medium was replaced with a regular medium and the cells were cultured for another 24 h before treatment.</p></sec><sec id="sec2dot10-molecules-23-01857"><title>2.10. Statistical Analysis</title><p>The statistical analysis was performed using Prism software (Prism 5.0, San Diego, CA, USA). The data were analyzed by Student&#x02019;s <italic>t</italic>-test, Student&#x02013;Newman&#x02013;Keuls&#x02019;s multiple-comparison test, or two-way ANOVA using SAS v 8.2 (SAS Inst. Inc., Cary, NC, USA). The Student&#x02013;Newman&#x02013;Keuls&#x02019;s multiple-comparison test was used for comparisons among the groups, and the LPS and NOX2 protein siRNA were used as factors in the two-way ANOVA. The values are presented as means &#x000b1; standard error of the mean (SEM), and those at <italic>p</italic> &#x0003c; 0.05 were considered significant. </p></sec></sec><sec id="sec3-molecules-23-01857"><title>3. Results</title><sec id="sec3dot1-molecules-23-01857"><title>3.1. OEO and LPS Induces Cytotoxicity in RAW264.7 Cells</title><p>The cytotoxic effects of OEO and LPS on RAW264.7 cells were evaluated using MTT and LDH release assays. Low doses of OEO (1.25&#x02013;20 &#x003bc;g/mL) did not cause any cytotoxicity, whereas doses of 80&#x02013;160 &#x003bc;g/mL for 24 h significantly reduced the cell viability and increased the LDH release compared with the untreated control cells (<xref ref-type="app" rid="app1-molecules-23-01857">Figure S2a,b</xref>). Based on these cell viability data, subsequent experiments were performed using OEO concentrations of &#x02264;10 &#x003bc;g/mL. The results of the RAW264.7 cell exposure to LPS are shown in <xref ref-type="app" rid="app1-molecules-23-01857">Figure S2c,d</xref>. The cells treated with LPS (100 &#x003bc;g/mL) showed significantly reduced viability and increased LDH release compared with the untreated control cells. To minimize the cytotoxic effect, treatment with 1 &#x003bc;g/mL LPS was selected for the subsequent experiments.</p></sec><sec id="sec3dot2-molecules-23-01857"><title>3.2. OEO Reduces LPS-Induced Expression of Inflammatory Mediators in RAW264.7 Cells</title><p>As shown in <xref ref-type="fig" rid="molecules-23-01857-f001">Figure 1</xref>a&#x02013;c, the production of IL-1&#x003b2;, IL-6, and TNF-&#x003b1; in RAW264.7 cells markedly increased in response to the LPS treatment for 12 h, whereas pretreatment with OEO (2.5&#x02013;10 &#x003bc;g/mL) for 12 h significantly inhibited the secretion of IL-1&#x003b2;, IL-6, and TNF-&#x003b1;. Furthermore, we examined the mRNA levels of IL-1&#x003b2;, IL-6, and TNF-&#x003b1; through an RT-PCR analysis (<xref ref-type="fig" rid="molecules-23-01857-f001">Figure 1</xref>d&#x02013;f). The treatment of RAW264.7 cells with LPS for 1 h dramatically induced the mRNA expression of IL-1&#x003b2;, IL-6, and TNF-&#x003b1;. Meanwhile, pretreatment with OEO (2.5&#x02013;10 &#x003bc;g/mL) inhibited the mRNA expression of IL-1&#x003b2;, IL-6, and TNF-&#x003b1; in the RAW264.7 cells stimulated with LPS.</p></sec><sec id="sec3dot3-molecules-23-01857"><title>3.3. OEO Inhibits LPS-Induced Activation of Protein Kinase B (AKT), MAPKs, and NF-&#x003ba;B in RAW264.7 Cells</title><p>The production of inflammatory mediators is strongly affected by the AKT, MAPKs, and NF-&#x003ba;B pathways in the RAW264.7 cells. P65 is the major component of the NF-&#x003ba;B activated by LPS in the RAW264.7 cells. As shown in <xref ref-type="fig" rid="molecules-23-01857-f002">Figure 2</xref>, the RAW264.7 cells were pretreated with OEO for 12 h and stimulated with LPS for 1 h. The OEO suppressed the LPS-induced phosphorylation of AKT and MAPKs (<xref ref-type="fig" rid="molecules-23-01857-f002">Figure 2</xref>a), while decreasing the NF-&#x003ba;B p65 concentration in a dose-dependent manner in the nucleus (<xref ref-type="fig" rid="molecules-23-01857-f002">Figure 2</xref>b).</p></sec><sec id="sec3dot4-molecules-23-01857"><title>3.4. OEO Inhibits LPS-Induced Oxidative Stress in RAW264.7 Cells</title><p>The RAW264.7 cells were exposed to LPS for different time intervals (0.25&#x02013;12 h). The increase in ROS generation started as early as 15 min, and the relative fluorescence peaked at 30 min, and subsequently maintained high levels at 6 and 12 h (<xref ref-type="fig" rid="molecules-23-01857-f003">Figure 3</xref>a). Intracellular ROS, as indicated by the DCF fluorescence, was observed with a fluorescence microscope. The RAW264.7 cells exposed to LPS for 30 min showed a significant increase in fluorescence (<xref ref-type="fig" rid="molecules-23-01857-f003">Figure 3</xref>b). This ROS induction was substantially inhibited by OEO pretreatment for 12 h (<xref ref-type="fig" rid="molecules-23-01857-f003">Figure 3</xref>c). The RAW264.7 cells&#x02019; supernatant of the ROS level was measured by luminol as a probe. The pretreatment with OEO for 12 h inhibited the ROS production in the RAW264.7 cell supernatants in the presence of LPS (<xref ref-type="fig" rid="molecules-23-01857-f003">Figure 3</xref>d).</p><p>The levels of malondialdehyde (MDA) were measured using the thiobarbituric acid reactive substances (TBARS) assay to investigate the effect of OEO on cell lipid peroxidation in cultured RAW264.7 cells. As shown in <xref ref-type="fig" rid="molecules-23-01857-f003">Figure 3</xref>e, the MDA levels in the RAW264.7 cells markedly increased in response to 24 h of LPS treatment, whereas pretreatment with OEO for 12 h significantly inhibited the lipid peroxidation. The exposure of RAW264.7 cells to LPS for 24 h decreased the GSH concentration and GSH: GSSG ratio in the cells. A pretreatment with OEO to the culture medium increased the GSH concentration and GSH: GSSG ratio in the cells (<xref ref-type="fig" rid="molecules-23-01857-f003">Figure 3</xref>f,g).</p></sec><sec id="sec3dot5-molecules-23-01857"><title>3.5. Inflammation Activation Induced by LPS Is Modulated by Nox2 in RAW264.7 Cells</title><p>NADPH oxidase is an enzymatic source for ROS production under various pathologic conditions. Nox2 is the catalytic subunit. DPI is a widely used inhibitor of NADPH oxidase [<xref rid="B15-molecules-23-01857" ref-type="bibr">15</xref>]. The NOX2 protein was downregulated by treatment with NOX2-siRNA, as shown in <xref ref-type="fig" rid="molecules-23-01857-f004">Figure 4</xref>a,b. The treatment with NOX2-siRNA approximately reduced the mRNA and protein expression of NOX2 by 49% and 51%, respectively. The treatment with NOX2-siRNA suppressed the LPS-induced increase in the NADPH oxidase activity (<xref ref-type="fig" rid="molecules-23-01857-f004">Figure 4</xref>c) and the ROS production (<xref ref-type="fig" rid="molecules-23-01857-f004">Figure 4</xref>d). Moreover, the treatment with NOX2-siRNA inhibited the mRNA expression of IL-1&#x003b2;, IL-6, and TNF-&#x003b1; in the RAW264.7 cells induced by LPS (<xref ref-type="fig" rid="molecules-23-01857-f004">Figure 4</xref>e&#x02013;g). The activity of the NADPH oxidase in the RAW264.7 cells increased in response to the LPS treatment for 30 min, whereas pretreatment with OEO or DPI significantly inhibited the activity of the NADPH oxidase (<xref ref-type="fig" rid="molecules-23-01857-f004">Figure 4</xref>h).</p></sec></sec><sec id="sec4-molecules-23-01857"><title>4. Discussion </title><p>Macrophages, as innate immune cells, initiate inflammation and immune response [<xref rid="B16-molecules-23-01857" ref-type="bibr">16</xref>]. LPS is the main component of endotoxin and is formed by a phosphoglycolipid or lipid A that is covalently linked to a hydrophilic heteropolysaccharide [<xref rid="B17-molecules-23-01857" ref-type="bibr">17</xref>]. When challenged with LPS, macrophages are activated and release various pro-inflammatory factors, such as IL-1&#x003b2;, IL-6, and TNF-&#x003b1; [<xref rid="B18-molecules-23-01857" ref-type="bibr">18</xref>]. The macrophage is activated as a defense mechanism, and is generally beneficial [<xref rid="B19-molecules-23-01857" ref-type="bibr">19</xref>]. However, if the inflammation is uncontrolled, the excessive release may result in extensive tissue damage and pathological changes [<xref rid="B20-molecules-23-01857" ref-type="bibr">20</xref>]. OEO exerts a significant anti-inflammatory effect in vitro and in vivo [<xref rid="B12-molecules-23-01857" ref-type="bibr">12</xref>,<xref rid="B21-molecules-23-01857" ref-type="bibr">21</xref>]. Our previous study found that OEO decreases the pro-inflammatory expression in pig models [<xref rid="B21-molecules-23-01857" ref-type="bibr">21</xref>]. However, the molecular mechanisms by which OEO improves the anti-inflammation status are unknown. </p><p>Importantly, the OEO concentrations (2.5&#x02013;10 &#x003bc;g/mL) used in the present study were non-cytotoxic and extremely low. OEO at similarly low concentrations demonstrates favorable pharmacological properties. For instance, the treatment of oxidized low density lipoprotein-activated THP-1 macrophages with OEO (10&#x02013;30 &#x003bc;g/mL) results in an overall reduction in pro-inflammatory cytokine release [<xref rid="B12-molecules-23-01857" ref-type="bibr">12</xref>]. Similarly, the anti-inflammation effects of the OEO components thymol and carvacrol (3&#x02013;6 &#x003bc;g/mL) have been demonstrated in high glucose-induced RAW264.7 cells [<xref rid="B22-molecules-23-01857" ref-type="bibr">22</xref>]. To elucidate the mechanisms by which these anti-inflammation effects are exerted, we initially assessed the effects of OEO on the pro-inflammatory secretion in the RAW264.7 cells. In the present study, the most sensitive indicators of the effectiveness of the OEO treatment were shown to be the inhibited expression of the pro-inflammatory cytokines, such as TNF-&#x003b1;, IL-1&#x003b2;, and IL-6. Furthermore, LPS is a potent activator for various downstream signal transductions, including MAPK, Akt, and NF-&#x003ba;B [<xref rid="B20-molecules-23-01857" ref-type="bibr">20</xref>,<xref rid="B23-molecules-23-01857" ref-type="bibr">23</xref>]. The activation of these typical pathways is associated with an increased expression of TNF-&#x003b1;, IL-1&#x003b2;, and IL-6 [<xref rid="B24-molecules-23-01857" ref-type="bibr">24</xref>]. Consistent with the inhibited expression of pro-inflammatory cytokines, the RAW264.7 cells treated with OEO showed a greater inhibition of the inflammation signaling pathway, including the MAPKs (e.g., p38 MAPK, ERK1/2, and JNK), Akt, and NF-&#x003ba;B signaling pathways.</p><p>ROS plays an important role in LPS-induced macrophage inflammation [<xref rid="B25-molecules-23-01857" ref-type="bibr">25</xref>]. ROS induces inflammation by stimulating MAPKs, Akt, and NF-&#x003ba;B [<xref rid="B26-molecules-23-01857" ref-type="bibr">26</xref>,<xref rid="B27-molecules-23-01857" ref-type="bibr">27</xref>]. The model used in the present study increases the generation of free radicals and other ROS in the RAW264.7 cells [<xref rid="B25-molecules-23-01857" ref-type="bibr">25</xref>]. The LPS treatment of the RAW264.7 cells dramatically increased the ROS production. Any imbalance between the production of these molecules and their safe disposal may culminate in oxidative stress. An in vitro study reported that OEO exerts an excellent anti-oxidative captivity by inhibiting lipid peroxidation and scavenging 2,2&#x02032;-diphenyl-1-picrylhydrazyl radicals [<xref rid="B28-molecules-23-01857" ref-type="bibr">28</xref>]. In the present study, OEO decreased ROS production in the RAW264.7 cells. MDA and GSH/GSSG are considered excellent indicators of oxidative stress [<xref rid="B29-molecules-23-01857" ref-type="bibr">29</xref>,<xref rid="B30-molecules-23-01857" ref-type="bibr">30</xref>]. OEO was beneficial in decreasing the MDA levels and increasing the GSH: GSSG ratio in the RAW264.7 cells induced by LPS. </p><p>The phagocyte NOX2 complex is a multicomponent enzyme composed of membrane-bound subunits (Nox2 protein and p22phox) and cytosolic subunits (p47phox, p67phox, and Rac) [<xref rid="B31-molecules-23-01857" ref-type="bibr">31</xref>]. The Nox2 protein acts as the catalytic subunit of the phagocyte NADPH oxidase [<xref rid="B32-molecules-23-01857" ref-type="bibr">32</xref>]. NOX2 is highly expressed in phagocytes and in the RAW264.7 cells [<xref rid="B31-molecules-23-01857" ref-type="bibr">31</xref>,<xref rid="B33-molecules-23-01857" ref-type="bibr">33</xref>]. The NOX2 in the phagocytes constitutes the primary source of ROS during an oxidative burst [<xref rid="B34-molecules-23-01857" ref-type="bibr">34</xref>]. The signal transduction and inflammatory response induced by LPS are related to the activity of NOX2 in a number of cells [<xref rid="B35-molecules-23-01857" ref-type="bibr">35</xref>,<xref rid="B36-molecules-23-01857" ref-type="bibr">36</xref>]. Previous results reported that LPS-induced superoxide formation and inflammatory are inhibited by silencing the Nox2 protein in human pulmonary microvascular endothelial cells [<xref rid="B32-molecules-23-01857" ref-type="bibr">32</xref>]. In conjunction with our Nox2 protein silencing data, the NOX2-siRNA knockdown of the Nox2 protein inhibited not only the LPS-induced generation of ROS, but also its protective effect against oxidative stress-induced inflammation in the RAW264.7 cells. These results supported the role of Nox2-induced ROS production in LPS-mediated pro-inflammation expression. Therefore, the inhibition of ROS production using inhibitors against the NADPH oxidase is proposed as an alternative approach to conventional antioxidant therapies against inflammation. We examined the effect of OEO on the activation of NADPH oxidase in the RAW264.7 cells induced by LPS. The results showed that the OEO inhibited the ROS production in the RAW264.7 cells by reducing the NADPH oxidase activity. These data are consistent with previous observations that <italic>Z. multiflora</italic> essential oil, thymol, and carvacrol (1&#x02013;100 ng/mL) significantly reduce the NADPH oxidase activity in the LPS-stimulated murine macrophage cells [<xref rid="B37-molecules-23-01857" ref-type="bibr">37</xref>].</p><p>In summary, the results of this study showed that the LPS induced RAW264.7 cell inflammatory response through regulating NADPH oxidase activation-driven oxidative stress. OEO effectively inhibited the expression of the LPS-induced inflammatory mediators in the RAW264.7 cells through the activation of NF-&#x003ba;B and the phosphorylation of AKT and MAPKs via scavenging intracellular ROS. The OEO supplementation can effectively antagonize the NADPH oxidase activation, thereby abolishing the oxidative stress in the LPS-induced RAW264.7 cells. Our study indicates that dietary supplementation with OEO blocks LPS-induced RAW264.7 cell inflammation through decreasing the cellular levels of ROS, directly and indirectly.</p></sec></body><back><fn-group><fn><p><bold>Sample Availability:</bold> Samples of the compounds are not available from the authors.</p></fn></fn-group><app-group><app id="app1-molecules-23-01857"><title>Supplementary Materials</title><p>Supplementary materials are available online, Figure S1: Typical chromatogram of oregano essential oil components, Figure S2: Oregano essential oil and LPS induced cytotoxicity in RAW264.7 cells, Table S1: Chemical composition of oregano essential oil components.</p><supplementary-material content-type="local-data" id="molecules-23-01857-s001"><media xlink:href="molecules-23-01857-s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>All authors contributed to the paper in the following ways: conception and design of the study (J.P.), acquisition of data (C.C., Y.Z.), analysis and interpretation of the data (J.P., C.C., Y.Z.), drafting the article (C.C.), revising the article (C.C., Y.Z.) and final approval (J.P., C.C., Y.Z.).</p></notes><notes><title>Funding</title><p>This study was supported by the National key Research and Development project of China [No. 2017YFD0502004], the National Natural Science Foundation of China [No. 31472075], and the China Agriculture Research System [No. CARS36].</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-molecules-23-01857"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujiwara</surname><given-names>N.</given-names></name><name><surname>Kobayashi</surname><given-names>K.</given-names></name></person-group><article-title>Macrophages in inflammation</article-title><source>Curr. Drug Targets-Inflamm. Allergy</source><year>2005</year><volume>4</volume><fpage>281</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.2174/1568010054022024</pub-id><?supplied-pmid 16101534?><pub-id pub-id-type="pmid">16101534</pub-id></element-citation></ref><ref id="B2-molecules-23-01857"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawai</surname><given-names>T.</given-names></name><name><surname>Adachi</surname><given-names>O.</given-names></name><name><surname>Ogawa</surname><given-names>T.</given-names></name><name><surname>Takeda</surname><given-names>K.</given-names></name><name><surname>Akira</surname><given-names>S.</given-names></name></person-group><article-title>Unresponsiveness of MyD88-Deficient Mice to Endotoxin</article-title><source>Immunity</source><year>1999</year><volume>11</volume><fpage>115</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(00)80086-2</pub-id><pub-id pub-id-type="pmid">10435584</pub-id></element-citation></ref><ref id="B3-molecules-23-01857"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Yin</surname><given-names>P.</given-names></name><name><surname>Wan</surname><given-names>C.</given-names></name><name><surname>Chong</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>M.</given-names></name><name><surname>Cheng</surname><given-names>P.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>F.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name></person-group><article-title>Punicalagin inhibits inflammation in LPS-induced RAW264. 7 macrophages via the suppression of TLR4-mediated MAPKs and NF-&#x003ba;B activation</article-title><source>Inflammation</source><year>2014</year><volume>37</volume><fpage>956</fpage><lpage>965</lpage><pub-id pub-id-type="doi">10.1007/s10753-014-9816-2</pub-id><?supplied-pmid 24473904?><pub-id pub-id-type="pmid">24473904</pub-id></element-citation></ref><ref id="B4-molecules-23-01857"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>I.T.</given-names></name><name><surname>Yang</surname><given-names>C.M.</given-names></name></person-group><article-title>Role of NADPH oxidase/ROS in pro-inflammatory mediators-induced airway and pulmonary diseases</article-title><source>Biochem. Pharmacol.</source><year>2012</year><volume>84</volume><fpage>581</fpage><pub-id pub-id-type="doi">10.1016/j.bcp.2012.05.005</pub-id><?supplied-pmid 22587816?><pub-id pub-id-type="pmid">22587816</pub-id></element-citation></ref><ref id="B5-molecules-23-01857"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>C.W.</given-names></name><name><surname>Short</surname><given-names>S.P.</given-names></name><name><surname>Williams</surname><given-names>C.S.</given-names></name></person-group><article-title>Selenoproteins and oxidative stress-induced inflammatory tumorigenesis in the gut</article-title><source>Cell. Mol. Life Sci.</source><year>2017</year><volume>74</volume><fpage>607</fpage><lpage>616</lpage><pub-id pub-id-type="doi">10.1007/s00018-016-2339-2</pub-id><?supplied-pmid 27563706?><pub-id pub-id-type="pmid">27563706</pub-id></element-citation></ref><ref id="B6-molecules-23-01857"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahman</surname><given-names>I.</given-names></name><name><surname>Adcock</surname><given-names>I.M.</given-names></name></person-group><article-title>Oxidative stress and redox regulation of lung inflammation in COPD</article-title><source>Eur. Respir. J.</source><year>2006</year><volume>28</volume><fpage>219</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1183/09031936.06.00053805</pub-id><?supplied-pmid 16816350?><pub-id pub-id-type="pmid">16816350</pub-id></element-citation></ref><ref id="B7-molecules-23-01857"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>G.Y.</given-names></name><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Brumell</surname><given-names>J.H.</given-names></name></person-group><article-title>The many roles of NOX2 NADPH oxidase-derived ROS in immunity</article-title><source>Semin. Immunopathol.</source><year>2010</year><volume>32</volume><fpage>415</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1007/s00281-010-0221-0</pub-id><?supplied-pmid 20803017?><pub-id pub-id-type="pmid">20803017</pub-id></element-citation></ref><ref id="B8-molecules-23-01857"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milos</surname><given-names>M.</given-names></name><name><surname>Mastelic</surname><given-names>J.</given-names></name><name><surname>Jerkovic</surname><given-names>I.</given-names></name></person-group><article-title>Chemical composition and antioxidant effect of glycosidically bound volatile compounds from oregano (<italic>Origanum vulgare</italic> L. ssp. hirtum)</article-title><source>Food Chem.</source><year>2000</year><volume>71</volume><fpage>79</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/S0308-8146(00)00144-8</pub-id></element-citation></ref><ref id="B9-molecules-23-01857"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakkali</surname><given-names>F.</given-names></name><name><surname>Averbeck</surname><given-names>S.</given-names></name><name><surname>Averbeck</surname><given-names>D.</given-names></name><name><surname>Idaomar</surname><given-names>M.</given-names></name></person-group><article-title>Biological effects of essential oils&#x02014;A review</article-title><source>Food Chem. Toxicol.</source><year>2008</year><volume>46</volume><fpage>446</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2007.09.106</pub-id><?supplied-pmid 17996351?><pub-id pub-id-type="pmid">17996351</pub-id></element-citation></ref><ref id="B10-molecules-23-01857"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foti</surname><given-names>M.C.</given-names></name><name><surname>Ingold</surname><given-names>K.U.</given-names></name></person-group><article-title>Mechanism of inhibition of lipid peroxidation by &#x003b3;-terpinene, an unusual and potentially useful hydrocarbon antioxidant</article-title><source>J. Agric. Food Chem.</source><year>2003</year><volume>51</volume><fpage>2758</fpage><lpage>2765</lpage><pub-id pub-id-type="doi">10.1021/jf020993f</pub-id><?supplied-pmid 12696969?><pub-id pub-id-type="pmid">12696969</pub-id></element-citation></ref><ref id="B11-molecules-23-01857"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bukovsk&#x000e1;</surname><given-names>A.</given-names></name><name><surname>Ciko&#x00161;</surname><given-names>&#x00160;.</given-names></name><name><surname>Juh&#x000e1;s</surname><given-names>&#x00160;.</given-names></name><name><surname>Il&#x02019;kov&#x000e1;</surname><given-names>G.</given-names></name><name><surname>Reh&#x000e1;k</surname><given-names>P.</given-names></name><name><surname>Koppel</surname><given-names>J.</given-names></name></person-group><article-title>Effects of a combination of thyme and oregano essential oils on TNBS-induced colitis in mice</article-title><source>Mediat. Inflamm.</source><year>2007</year><volume>2007</volume><fpage>23296</fpage><pub-id pub-id-type="doi">10.1155/2007/23296</pub-id><?supplied-pmid 18288268?><pub-id pub-id-type="pmid">18288268</pub-id></element-citation></ref><ref id="B12-molecules-23-01857"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ocana-Fuentes</surname><given-names>A.</given-names></name><name><surname>Arranz-Guti&#x000e9;rrez</surname><given-names>E.</given-names></name><name><surname>Senorans</surname><given-names>F.J.</given-names></name><name><surname>Reglero</surname><given-names>G.</given-names></name></person-group><article-title>Supercritical fluid extraction of oregano (<italic>Origanum vulgare</italic>) essentials oils: Anti-inflammatory properties based on cytokine response on THP-1 macrophages</article-title><source>Food Chem. Toxicol.</source><year>2010</year><volume>48</volume><fpage>1568</fpage><lpage>1575</lpage><pub-id pub-id-type="pmid">20332013</pub-id></element-citation></ref><ref id="B13-molecules-23-01857"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname><given-names>K.J.</given-names></name><name><surname>Schmittgen</surname><given-names>T.D.</given-names></name></person-group><article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2&#x02212;&#x00394;&#x00394;CT method</article-title><source>Methods</source><year>2001</year><volume>25</volume><fpage>402</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id><?supplied-pmid 11846609?><pub-id pub-id-type="pmid">11846609</pub-id></element-citation></ref><ref id="B14-molecules-23-01857"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname><given-names>Y.</given-names></name><name><surname>Xiang</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Peng</surname><given-names>J.</given-names></name><name><surname>Wei</surname><given-names>H.</given-names></name></person-group><article-title>Oregano Essential Oil Improves Intestinal Morphology and Expression of Tight Junction Proteins Associated with Modulation of Selected Intestinal Bacteria and Immune Status in a Pig Model</article-title><source>BioMed Res. Int.</source><year>2016</year><volume>2016</volume><fpage>5436738</fpage><pub-id pub-id-type="doi">10.1155/2016/5436738</pub-id><?supplied-pmid 27314026?><pub-id pub-id-type="pmid">27314026</pub-id></element-citation></ref><ref id="B15-molecules-23-01857"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keshari</surname><given-names>R.S.</given-names></name><name><surname>Verma</surname><given-names>A.</given-names></name><name><surname>Barthwal</surname><given-names>M.K.</given-names></name><name><surname>Dikshit</surname><given-names>M.</given-names></name></person-group><article-title>Reactive oxygen species-induced activation of ERK and p38 MAPK mediates PMA-induced NETs release from human neutrophils</article-title><source>J. Cell. Biochem.</source><year>2013</year><volume>114</volume><fpage>532</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.1002/jcb.24391</pub-id><?supplied-pmid 22961925?><pub-id pub-id-type="pmid">22961925</pub-id></element-citation></ref><ref id="B16-molecules-23-01857"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laskin</surname><given-names>D.L.</given-names></name><name><surname>Pendino</surname><given-names>K.J.</given-names></name></person-group><article-title>Macrophages and inflammatory mediators in tissue injury</article-title><source>Annu. Rev. Pharmacol. Toxicol.</source><year>1995</year><volume>35</volume><fpage>655</fpage><lpage>677</lpage><pub-id pub-id-type="doi">10.1146/annurev.pa.35.040195.003255</pub-id><?supplied-pmid 7598511?><pub-id pub-id-type="pmid">7598511</pub-id></element-citation></ref><ref id="B17-molecules-23-01857"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rietschel</surname><given-names>E.T.</given-names></name><name><surname>Kirikae</surname><given-names>T.</given-names></name><name><surname>Schade</surname><given-names>F.U.</given-names></name><name><surname>Mamat</surname><given-names>U.</given-names></name><name><surname>Schmidt</surname><given-names>G.</given-names></name><name><surname>Loppnow</surname><given-names>H.</given-names></name><name><surname>Ulmer</surname><given-names>A.J.</given-names></name><name><surname>Z&#x000e4;hringer</surname><given-names>U.</given-names></name><name><surname>Seydel</surname><given-names>U.</given-names></name><name><surname>di Padova</surname><given-names>F.</given-names></name></person-group><article-title>Bacterial endotoxin: Molecular relationships of structure to activity and function</article-title><source>FASEB J.</source><year>1994</year><volume>8</volume><fpage>217</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1096/fasebj.8.2.8119492</pub-id><?supplied-pmid 8119492?><pub-id pub-id-type="pmid">8119492</pub-id></element-citation></ref><ref id="B18-molecules-23-01857"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H.G.</given-names></name><name><surname>Shrestha</surname><given-names>B.</given-names></name><name><surname>Lim</surname><given-names>S.Y.</given-names></name><name><surname>Yoon</surname><given-names>D.H.</given-names></name><name><surname>Chang</surname><given-names>W.C.</given-names></name><name><surname>Shin</surname><given-names>D.-J.</given-names></name><name><surname>Han</surname><given-names>S.K.</given-names></name><name><surname>Park</surname><given-names>S.M.</given-names></name><name><surname>Park</surname><given-names>J.H.</given-names></name><name><surname>Park</surname><given-names>H.I.</given-names></name></person-group><article-title>Cordycepin inhibits lipopolysaccharide-induced inflammation by the suppression of NF-&#x003ba;B through Akt and p38 inhibition in RAW 264.7 macrophage cells</article-title><source>Eur. J. Pharmacol.</source><year>2006</year><volume>545</volume><fpage>192</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2006.06.047</pub-id><?supplied-pmid 16899239?><pub-id pub-id-type="pmid">16899239</pub-id></element-citation></ref><ref id="B19-molecules-23-01857"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamkanfi</surname><given-names>M.</given-names></name><name><surname>Dixit</surname><given-names>V.M.</given-names></name></person-group><article-title>Inflammasomes and their roles in health and disease</article-title><source>Annu. Rev. Cell Dev. Biol.</source><year>2012</year><volume>28</volume><fpage>137</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1146/annurev-cellbio-101011-155745</pub-id><?supplied-pmid 22974247?><pub-id pub-id-type="pmid">22974247</pub-id></element-citation></ref><ref id="B20-molecules-23-01857"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xavier</surname><given-names>R.</given-names></name><name><surname>Podolsky</surname><given-names>D.</given-names></name></person-group><article-title>Unravelling the pathogenesis of inflammatory bowel disease</article-title><source>Nature</source><year>2007</year><volume>448</volume><fpage>427</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1038/nature06005</pub-id><?supplied-pmid 17653185?><pub-id pub-id-type="pmid">17653185</pub-id></element-citation></ref><ref id="B21-molecules-23-01857"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Peng</surname><given-names>J.</given-names></name><name><surname>Wei</surname><given-names>H.</given-names></name></person-group><article-title>Oregano Essential Oil Induces SOD1 and GSH Expression through Nrf2 Activation and Alleviates Hydrogen Peroxide-Induced Oxidative Damage in IPEC-J2 Cells</article-title><source>Oxidative Med. Cell. Longev.</source><year>2016</year><volume>2016</volume><fpage>5987183</fpage><pub-id pub-id-type="doi">10.1155/2016/5987183</pub-id><?supplied-pmid 28105249?><pub-id pub-id-type="pmid">28105249</pub-id></element-citation></ref><ref id="B22-molecules-23-01857"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kavoosi</surname><given-names>G.</given-names></name><name><surname>da Silva</surname><given-names>J.A.T.</given-names></name></person-group><article-title>Inhibitory effects of <italic>Zataria multiflora</italic> essential oil and its main components on nitric oxide and hydrogen peroxide production in glucose-stimulated human monocyte</article-title><source>Food Chem. Toxicol.</source><year>2012</year><volume>9</volume><fpage>3079</fpage><lpage>3085</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2012.06.002</pub-id><?supplied-pmid 22705771?><pub-id pub-id-type="pmid">22705771</pub-id></element-citation></ref><ref id="B23-molecules-23-01857"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Intayoung</surname><given-names>P.</given-names></name><name><surname>Limtrakul</surname><given-names>P.</given-names></name><name><surname>Yodkeeree</surname><given-names>S.</given-names></name></person-group><article-title>Antiinflammatory Activities of Crebanine by Inhibition of NF-&#x003ba;B and AP-1 Activation through Suppressing MAPKs and Akt Signaling in LPS-Induced RAW264. 7 Macrophages</article-title><source>Biol. Pharm. Bull.</source><year>2016</year><volume>39</volume><fpage>54</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1248/bpb.b15-00479</pub-id><?supplied-pmid 26499331?><pub-id pub-id-type="pmid">26499331</pub-id></element-citation></ref><ref id="B24-molecules-23-01857"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neurath</surname><given-names>M.F.</given-names></name></person-group><article-title>Cytokines in inflammatory bowel disease</article-title><source>Nat. Rev. Immunol.</source><year>2014</year><volume>14</volume><fpage>329</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1038/nri3661</pub-id><?supplied-pmid 24751956?><pub-id pub-id-type="pmid">24751956</pub-id></element-citation></ref><ref id="B25-molecules-23-01857"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heo</surname><given-names>S.K.</given-names></name><name><surname>Yi</surname><given-names>H.S.</given-names></name><name><surname>Yun</surname><given-names>H.J.</given-names></name><name><surname>Ko</surname><given-names>C.H.</given-names></name><name><surname>Choi</surname><given-names>J.W.</given-names></name><name><surname>Park</surname><given-names>S.D.</given-names></name></person-group><article-title>Ethylacetate extract from DraconisResina inhibits LPS-induced inflammatory responses in vascular smooth muscle cells and macrophages via suppression of ROS production</article-title><source>Food Chem. Toxicol.</source><year>2010</year><volume>48</volume><fpage>1129</fpage><lpage>1136</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2009.06.043</pub-id><?supplied-pmid 19577610?><pub-id pub-id-type="pmid">19577610</pub-id></element-citation></ref><ref id="B26-molecules-23-01857"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Son</surname><given-names>Y.</given-names></name><name><surname>Cheong</surname><given-names>Y.-K.</given-names></name><name><surname>Kim</surname><given-names>N.-H.</given-names></name><name><surname>Chung</surname><given-names>H.-T.</given-names></name><name><surname>Kang</surname><given-names>D.G.</given-names></name><name><surname>Pae</surname><given-names>H.-O.</given-names></name></person-group><article-title>Mitogen-activated protein kinases and reactive oxygen species: How can ROS activate MAPK pathways?</article-title><source>J. Signal. Transduct.</source><year>2011</year><volume>2011</volume><fpage>792639</fpage><pub-id pub-id-type="doi">10.1155/2011/792639</pub-id><?supplied-pmid 21637379?><pub-id pub-id-type="pmid">21637379</pub-id></element-citation></ref><ref id="B27-molecules-23-01857"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>S.</given-names></name><name><surname>Xin</surname><given-names>Y.</given-names></name><name><surname>Guo</surname><given-names>Y.</given-names></name><name><surname>Diao</surname><given-names>Y.</given-names></name><name><surname>Kou</surname><given-names>X.</given-names></name><name><surname>Luo</surname><given-names>L.</given-names></name><name><surname>Yin</surname><given-names>Z.</given-names></name></person-group><article-title>Ampelopsin reduces endotoxic inflammation via repressing ROS-mediated activation of PI3K/Akt/NF-&#x003ba;B signaling pathways</article-title><source>Int. Immunopharmacol.</source><year>2012</year><volume>12</volume><fpage>278</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2011.12.001</pub-id><?supplied-pmid 22193240?><pub-id pub-id-type="pmid">22193240</pub-id></element-citation></ref><ref id="B28-molecules-23-01857"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulisic</surname><given-names>T.</given-names></name><name><surname>Radonic</surname><given-names>A.</given-names></name><name><surname>Katalinic</surname><given-names>V.</given-names></name><name><surname>Milos</surname><given-names>M.</given-names></name></person-group><article-title>Use of different methods for testing antioxidative activity of oregano essential oil</article-title><source>Food Chem.</source><year>2004</year><volume>85</volume><fpage>633</fpage><lpage>640</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2003.07.024</pub-id></element-citation></ref><ref id="B29-molecules-23-01857"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>E.</given-names></name><name><surname>Galougahi</surname><given-names>K.K.</given-names></name><name><surname>Liu</surname><given-names>C.-C.</given-names></name><name><surname>Bhindi</surname><given-names>R.</given-names></name><name><surname>Figtree</surname><given-names>G.A.</given-names></name></person-group><article-title>Biological markers of oxidative stress: Applications to cardiovascular research and practice</article-title><source>Redox Biol.</source><year>2013</year><volume>1</volume><fpage>483</fpage><lpage>491</lpage><pub-id pub-id-type="doi">10.1016/j.redox.2013.07.006</pub-id><?supplied-pmid 24251116?><pub-id pub-id-type="pmid">24251116</pub-id></element-citation></ref><ref id="B30-molecules-23-01857"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valko</surname><given-names>M.</given-names></name><name><surname>Leibfritz</surname><given-names>D.</given-names></name><name><surname>Moncol</surname><given-names>J.</given-names></name><name><surname>Cronin</surname><given-names>M.T.D.</given-names></name><name><surname>Mazur</surname><given-names>M.</given-names></name><name><surname>Telser</surname><given-names>J.</given-names></name></person-group><article-title>Free radicals and antioxidants in normal physiological functions and human disease</article-title><source>Int. J. Biochem. Cell Biol.</source><year>2007</year><volume>39</volume><fpage>44</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/j.biocel.2006.07.001</pub-id><?supplied-pmid 16978905?><pub-id pub-id-type="pmid">16978905</pub-id></element-citation></ref><ref id="B31-molecules-23-01857"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bedard</surname><given-names>K.</given-names></name><name><surname>Krause</surname><given-names>K.-H.</given-names></name></person-group><article-title>The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology</article-title><source>Physiol. Rev.</source><year>2007</year><volume>87</volume><fpage>245</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1152/physrev.00044.2005</pub-id><?supplied-pmid 17237347?><pub-id pub-id-type="pmid">17237347</pub-id></element-citation></ref><ref id="B32-molecules-23-01857"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menden</surname><given-names>H.</given-names></name><name><surname>Welak</surname><given-names>S.</given-names></name><name><surname>Cossette</surname><given-names>S.</given-names></name><name><surname>Ramchandran</surname><given-names>R.</given-names></name><name><surname>Sampath</surname><given-names>V.</given-names></name></person-group><article-title>Lipopolysaccharide (LPS)-mediated angiopoietin-2-dependent autocrine angiogenesis is regulated by NADPH oxidase 2 (Nox2) in human pulmonary microvascular endothelial cells</article-title><source>J. Biol. Chem.</source><year>2015</year><volume>290</volume><fpage>5449</fpage><lpage>5461</lpage><pub-id pub-id-type="doi">10.1074/jbc.M114.600692</pub-id><?supplied-pmid 25568324?><pub-id pub-id-type="pmid">25568324</pub-id></element-citation></ref><ref id="B33-molecules-23-01857"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasaki</surname><given-names>H.</given-names></name><name><surname>Yamamoto</surname><given-names>H.</given-names></name><name><surname>Tominaga</surname><given-names>K.</given-names></name><name><surname>Masuda</surname><given-names>K.</given-names></name><name><surname>Kawai</surname><given-names>T.</given-names></name><name><surname>Teshima-Kondo</surname><given-names>S.</given-names></name><name><surname>Rokutan</surname><given-names>K.</given-names></name></person-group><article-title>NADPH oxidase-derived reactive oxygen species are essential for differentiation of a mouse macrophage cell line (RAW264. 7) into osteoclasts</article-title><source>J. Med. Investig.</source><year>2009</year><volume>56</volume><fpage>33</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.2152/jmi.56.33</pub-id><pub-id pub-id-type="pmid">19262012</pub-id></element-citation></ref><ref id="B34-molecules-23-01857"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Neill</surname><given-names>H.C.</given-names></name><name><surname>Rancourt</surname><given-names>R.C.</given-names></name><name><surname>White</surname><given-names>C.W.</given-names></name></person-group><article-title>Lipoic acid suppression of neutrophil respiratory burst: Effect of NADPH</article-title><source>Antioxid. Redox Signal.</source><year>2008</year><volume>10</volume><fpage>277</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1089/ars.2007.1890</pub-id><?supplied-pmid 18158760?><pub-id pub-id-type="pmid">18158760</pub-id></element-citation></ref><ref id="B35-molecules-23-01857"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>F.</given-names></name><name><surname>Qian</surname><given-names>L.H.</given-names></name><name><surname>Deng</surname><given-names>B.</given-names></name><name><surname>Liu</surname><given-names>Z.M.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Le</surname><given-names>Y.Y.</given-names></name></person-group><article-title>Resveratrol Protects Vascular Endothelial Cells from High Glucose&#x02013;Induced Apoptosis through Inhibition of NADPH Oxidase Activation&#x02013;Driven Oxidative Stress</article-title><source>CNS Neurosci. Ther.</source><year>2013</year><volume>19</volume><fpage>675</fpage><lpage>681</lpage><pub-id pub-id-type="doi">10.1111/cns.12131</pub-id><?supplied-pmid 23731528?><pub-id pub-id-type="pmid">23731528</pub-id></element-citation></ref><ref id="B36-molecules-23-01857"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>I.T.</given-names></name><name><surname>Shih</surname><given-names>R.H.</given-names></name><name><surname>Lin</surname><given-names>C.C.</given-names></name><name><surname>Chen</surname><given-names>J.T.</given-names></name><name><surname>Yang</surname><given-names>C.M.</given-names></name></person-group><article-title>Role of TLR4/NADPH oxidase/ROS-activated p38 MAPK in VCAM-1 expression induced by lipopolysaccharide in human renal mesangial cells</article-title><source>Cell Commun. Signal.</source><year>2012</year><volume>10</volume><fpage>33</fpage><pub-id pub-id-type="doi">10.1186/1478-811X-10-33</pub-id><?supplied-pmid 23153039?><pub-id pub-id-type="pmid">23153039</pub-id></element-citation></ref><ref id="B37-molecules-23-01857"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kavoosi</surname><given-names>G.</given-names></name><name><surname>da Silva</surname><given-names>J.A.T.</given-names></name><name><surname>Saharkhiz</surname><given-names>M.J.</given-names></name></person-group><article-title>Inhibitory effects of <italic>Zataria multiflora</italic> essential oil and its main components on nitric oxide and hydrogen peroxide production in lipopolysaccharide-stimulated macrophages</article-title><source>Food Chem. Toxicol.</source><year>2012</year><volume>64</volume><fpage>1491</fpage><lpage>1500</lpage></element-citation></ref></ref-list></back><floats-group><fig id="molecules-23-01857-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Oregano essential oil (OEO) inhibits lipopolysaccharide (LPS)-induced mRNA levels of pro-inflammatory cytokines expression in murine macrophage cells (RAW264.7 cells). (<bold>a</bold>&#x02013;<bold>c</bold>) Cells were pretreated with OEO for 12 h, then incubated with 1 &#x003bc;g/mL LPS for 12 h. (<bold>d</bold>&#x02013;<bold>f</bold>) Cells were pretreated with OEO for 12 h, then incubated with 1 &#x003bc;g/mL LPS for 1 h. The interleukin-1 beta (IL-1&#x003b2;), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-&#x003b1;) mRNA expression levels were measured using an RT-PCR analysis. Values represent means &#x000b1; standard error of the mean (SEM), <italic>n</italic> = 3. <sup>#</sup>
<italic>p</italic> &#x0003c; 0.05 and <sup>##</sup>
<italic>p</italic> &#x0003c; 0.01 compared to the control group, while * <italic>p</italic> &#x0003c; 0.05 and ** <italic>p</italic> &#x0003c; 0.01 compared to the LPS-treated group.</p></caption><graphic xlink:href="molecules-23-01857-g001"/></fig><fig id="molecules-23-01857-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>OEO inhibits LPS-induced AKT, MAPKs, and NF-&#x003ba;B activation in the RAW264.7 cells. (<bold>a</bold>) Cells were pretreated with OEO for 12 h, then incubated with 1 &#x003bc;g/mL LPS for 1 h. MAPKs and AKT were estimated by Western blot. (<bold>b</bold>) Cells were pretreated with OEO for 12 h, then incubated with 1 &#x003bc;g/mL LPS for 1 h. Western blot results show the effects of OEO on the protein levels of NF-&#x003ba;B p65 in the nuclear fractions. ERK1/2&#x02014;extracellular signal-regulated kinases 1/2; JNK&#x02014;c-Jun N-terminal protein kinase; P38&#x02014;p38; Akt&#x02014;protein kinase B; NF-&#x003ba;B&#x02014;nuclear factor kappa B; P&#x02014;phosphorylated; T&#x02014;total. Values represent means &#x000b1; SEM, <italic>n</italic> = 3. <sup>#</sup>
<italic>p</italic> &#x0003c; 0.05 and <sup>##</sup>
<italic>p</italic> &#x0003c; 0.01 compared to the control group, while * <italic>p</italic> &#x0003c; 0.05 and ** <italic>p</italic> &#x0003c; 0.01 compared to the LPS-treated group.</p></caption><graphic xlink:href="molecules-23-01857-g002"/></fig><fig id="molecules-23-01857-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>OEO inhibits LPS-induced oxidative stress in RAW264.7 cells. (<bold>a</bold>) The RAW264.7 cells were incubated with 1 &#x003bc;g/mL of LPS. The fluorescence intensity of the dichlorofluorescein (DCF)-stained cells was quantified using a flow cytometer. (<bold>b</bold>) Cells were pretreated with OEO for 12 h, then incubated with 1 &#x003bc;g/mL of LPS for 30 min. The intracellular reactive oxygen species (ROS) levels were indicated by DCF fluorescence and detected by fluorescence microscopy. (<bold>c</bold>) Cells were pretreated with OEO for 12 h, then incubated with 1 &#x003bc;g/mL LPS for 30 min. The fluorescence intensity of DCF-stained cells was quantified using a multidetection reader. (<bold>d</bold>) Cells were pretreated with OEO (2.5&#x02013;10 &#x003bc;g/mL) for 12 h, then incubated with 1 &#x003bc;g/mL of LPS for 30 min. The levels of ROS in the culture supernatant were measured by chemiluminescence. (<bold>e</bold>&#x02013;<bold>g</bold>) Cells were pretreated with OEO for 12 h, then incubated with 1 &#x003bc;g/mL of LPS for 12 h. The intracellular malondialdehyde (MDA), the glutathione (GSH) levels and GSH: oxidized glutathione (GSSG) ration were measured. Values represent means &#x000b1; SEM, <italic>n</italic> = 3. <sup>#</sup>
<italic>p</italic> &#x0003c; 0.05 and <sup>##</sup>
<italic>p</italic> &#x0003c; 0.01 compared to the control group, while * <italic>p</italic> &#x0003c; 0.05 and ** <italic>p</italic> &#x0003c; 0.01 compared to the LPS-treated group.</p></caption><graphic xlink:href="molecules-23-01857-g003"/></fig><fig id="molecules-23-01857-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Effect of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 2 (NOX2) silencing on LPS-induced ROS production and inflammatory cytokines mRNA expression in RAW264.7 cells. (<bold>a</bold>,<bold>b</bold>) RAW264.7 cells were treated with NOX2-siRNA or control siRNA, and incubated for 24 h. (<bold>a</bold>) <italic>NOX2</italic> mRNA expression levels were measured using RT-PCR. (<bold>b</bold>) NOX2 protein expression levels were measured using Western blotting. (<bold>c</bold>) RAW264.7 cells were transfected with siRNA against NOX2 or control siRNA. After 24 h, the cells were incubated with LPS 1 &#x003bc;g/mL for 30 min. NADPH oxidases levels were measured using commercially ELISA kits. (<bold>d</bold>) RAW264.7 cells were transfected with siRNA against NOX2 or control siRNA. After 24 h, the cells were incubated with 1 &#x003bc;g/mL of LPS for 30 min. The fluorescence intensity of the DCF-stained cells was quantified using a multidetection reader. (<bold>e</bold>&#x02013;<bold>g</bold>) RAW264.7 cells were transfected with siRNA against NOX2 or control siRNA. After 24 h, the cells were incubated with 1 &#x003bc;g/mL LPS for 1 h, and the IL-1&#x003b2;, IL-6, and TNF-&#x003b1; mRNA expression levels were measured using RT-PCR. (<bold>h</bold>) Cells were pretreated with OEO for 12 h or diphenyleneiodonium chloride (DPI) (10 &#x003bc;M) for 1 h, then incubated with 1 &#x003bc;g/mL LPS for 30 min. NADPH oxidases levels were measured using commercially available ELISA kits. Values represent means &#x000b1; SEM, <italic>n</italic> = 3. <sup>#</sup>
<italic>p</italic> &#x0003c; 0.05 and <sup>##</sup>
<italic>p</italic> &#x0003c; 0.01 compared to the control group, while * <italic>p</italic> &#x0003c; 0.05 and ** <italic>p</italic> &#x0003c; 0.01 compared to the control-siRNA group (<bold>a</bold>&#x02013;<bold>g</bold>) or the LPS-treated group (<bold>h</bold>).</p></caption><graphic xlink:href="molecules-23-01857-g004"/></fig><table-wrap id="molecules-23-01857-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-23-01857-t001_Table 1</object-id><label>Table 1</label><caption><p>Sequence information on the primers used for quantitative PCR. IL&#x02014;interleukin; TNR&#x02014;tumor necrosis factor.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Gene</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Primer Sequence (Forward/Reverse 5&#x02032;-3&#x02032;)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Product Size (bp)</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>IL-1&#x003b2;</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">forward: ATGGCAACTGTCCCTGAACTCAACT<break/>reverse: CAGGACAGGTATAGATTCAACCCCTT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">560</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>IL-6</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">forward: CCAGTTGCCTTCTTGGGACTGATG<break/>reverse: ATTTTCTGACCACAGTGAGGAATG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">662</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>TNF-&#x003b1;</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">forward: ATGAGCACGGAAAGCATGATCCGA<break/>reverse: CCAAAGTAGACCTGCCCGGACTC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">692</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>&#x003b2;-actin</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">forward: GGAGATTACTGCCCTGGCTCCTA<break/>reverse: GACTCATCGTACTCCTGCTTGCTG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">101</td></tr></tbody></table></table-wrap></floats-group></article>